UMI3 – The University of Manchester Innovation Group
Two of the key people at UMI3, The University of Manchester’s innovation company, are Dr Luke Hakes, Chairman, and Clive Rowland, Chief Executive.
Chairman, Dr Luke Hakes
A triple graduate of the University in biochemistry with biotechnology; bioinformatics; and computational genetics, Luke completed his PhD in 2006. He is currently Investment Director at venture capital firm, Octopus Ventures, based in the City of London.
Over the last eight years Luke has advised and been a board member of a number of University spin-out companies. In addition he has held numerous non-executive directorships at start up and growth companies and has considerable experience of building and exiting businesses in the disruptive technology arena.
Outside of Octopus, Luke is an angel investor and adviser to a number of early-stage companies, with a particular interest in the artificial intelligence and genomics spaces.
CEO, Clive Rowland
Clive has a background and experience which includes industrial marketing, engineering management training and management consulting. He was initially responsible for industrial liaison, contracts and consulting at the University before developing its technology transfer activities.
Clive was also a team member of the University’s first managed spin-out, CPS Limited, which later formed part of the basis of Manchester-based ENER-G group. Clive assisted in its subsequent stock-market flotation and ENER-G group is now a successful environmental and energy company, with an annual turnover of £130 million and 750 employees.
Clive is a fellow of the Chartered Institute of Marketing, a fellow of the Institute of Directors, and he has received the Freedom of the City of London and the Italian Order of Merit.
Visit the UMI3 website to find out more about our innovation and enterprise.